|
|
 Healthcare-acquired, antibiotic-resistant infections kill 8,000 Canadian patients each year.1,2 They cost patients an average 39 extra days in the hospital2 and healthcare systems at least $100 million annually.1,2 Meanwhile, controlling the source of these harmful organisms on patients’ skin is a key component in reducing transmission between patients, staff, visitors and the healthcare environment.3,4
For patients at risk for healthcare-acquired infections (HAIs)—including those known or suspected to be colonized by resistant organisms—there is a new method of skin decolonization. Antiseptic body cleansing with 2% chlorhexidine gluconate (CHG) washcloths has been proven effective against a wide range of pathogens, including methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant enterococci (VRE), acinetobacter baumannii and more.5 |
| |
| 1. ‘Superbug' infections spiralling in Canadian hospitals. Canadian Broadcasting Corporation (CBC) News. 23 Mar 2005.
2. Invisible dangers: are Canadian hospitals doing enough to fight infections? Canadian Broadcasting Corporation (CBC) Investigative Unit. 21 Mar 2005.
3. Bleasdale SC, et. al., Skin Cleansing with 2% Chlorhexidine Gluconate (CHG): Infection Control and Clinical Benefits of Source Control. Presented at the 2006 Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Sep 2006, San Francisco, CA.
4. Vernon MO, et al., Arch Intern Med. 13 Feb 2006;166:306-12.
5. Time Kill and MIC Testing conducted by an independent laboratory; data on file.
|
| |
| This area of our website and its content is intended for healthcare professionals in Canada only. |
| |
|
